Introduction to drug-related lupus.
D000107:Acetylation; D000123:Acetyltransferases; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects; D001327:Autoimmune Diseases / Q000209:etiology; D002648:Child; D002746:Chlorpromazine / Q000009:adverse effects; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000276:immunology; D008297:Male; D010640:Phenothiazines / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D013411:Sulfadiazine / Q000009:adverse effects
D000927:Anticonvulsants; D010640:Phenothiazines; D013411:Sulfadiazine; D006830:Hydralazine; D000123:Acetyltransferases; D011342:Procainamide; D002746:Chlorpromazine